|
Volumn 18, Issue 2, 1999, Pages 139-142
|
Does PGE1 attenuate potassium-induced vasoconstriction in initial pulmonary artery flush on lung preservation?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
DEXTRAN;
NIFEDIPINE;
POTASSIUM;
PROSTAGLANDIN E1;
PRESERVATION SOLUTION;
RYANODINE;
VASODILATOR AGENT;
ADOLESCENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
EXPERIMENTAL MODEL;
EXPERIMENTAL TRANSPLANTATION;
INTRAARTERIAL DRUG ADMINISTRATION;
ISOLATED LUNG;
LUNG TRANSPLANTATION;
LUNG VASOCONSTRICTION;
MALE;
NONHUMAN;
ORGAN PRESERVATION;
PRIORITY JOURNAL;
RAT;
ANIMAL;
LUNG;
PULMONARY ARTERY;
SPRAGUE DAWLEY RAT;
VASCULARIZATION;
VASOCONSTRICTION;
ALPROSTADIL;
ANIMALS;
CALCIUM CHANNEL BLOCKERS;
INJECTIONS, INTRA-ARTERIAL;
LUNG;
LUNG TRANSPLANTATION;
MALE;
NIFEDIPINE;
ORGAN PRESERVATION;
ORGAN PRESERVATION SOLUTIONS;
POTASSIUM;
PULMONARY ARTERY;
RATS;
RATS, SPRAGUE-DAWLEY;
RYANODINE;
VASOCONSTRICTION;
VASODILATOR AGENTS;
|
EID: 0032587708
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: 10.1016/S1053-2498(98)00003-5 Document Type: Article |
Times cited : (8)
|
References (11)
|